CGTX
COGNITION THERAPEUTICS INC
Key Financials
Net Income
$-23487000
↑ 30.9%
Operating Income
$-47799000
↑ 11.4%
Total Assets
$48.4M
↑ 60.1%
EPS (Diluted)
$-0.32
↑ 62.8%
Total Liabilities
$14.1M
↑ 22.9%
Shareholders' Equity
$34.3M
↑ 82.8%
Cash & Equivalents
$36.8M
↑ 47.2%
Operating Cash Flow
$-24588000.00
↑ 13.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-8 | 3/26/2026 | View on SEC |
| 10-K | 3/26/2026 | View on SEC |
| 8-K | 3/26/2026 | View on SEC |
| 8-K | 3/2/2026 | View on SEC |
| 4 | 2/18/2026 | View on SEC |
| 4 | 2/18/2026 | View on SEC |
| 4 | 2/18/2026 | View on SEC |
| 4 | 2/5/2026 | View on SEC |
| 4 | 2/5/2026 | View on SEC |
| 4 | 2/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CGTX |
| Company Name | COGNITION THERAPEUTICS INC |
| CIK | 1455365 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 412-481-2210 |